Cetera Advisor Networks LLC Natera, Inc. Transaction History

Cetera Advisor Networks LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$59.21 - $92.9 $142,873 - $224,167	2,413 Added 23.36%	12,743 $1.17 Million
Q4 2023 Feb 13, 2024	BUY	$37.55 - $62.64 $55,649 - $92,832	1,482 Added 16.75%	10,330 $647,000
Q3 2023 Nov 14, 2023	BUY	$43.4 - $62.52 $69,483 - $100,094	1,601 Added 22.09%	8,848 $391,000
Q2 2023 Aug 09, 2023	BUY	$47.08 - $55.16 $117,511 - $137,679	2,496 Added 52.54%	7,247 $352,000
Q1 2023 May 15, 2023	BUY	$36.57 - $58.29 $173,744 - $276,935	4,751 New	4,751 $263,000
Q3 2020 Nov 13, 2020	SELL	$45.89 - $72.67 $7,021 - $11,118	-153 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$26.36 - $49.86 $4,033 - $7,628	153 New	153 $8,000

528

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisor Networks LLC with notifications on news.